POST Online Media Lite Edition



 

Epizyme appoints Jason P. Rhodes president

Staff writer |
Cambridge, Mass., USA – Epizyme, Inc., a clinical stage biopharmaceutical company, announced that Jason P. Rhodes has been named president of Epizyme.[break]


Mr. Rhodes, who was previously Executive Vice President and Chief Financial Officer, will continue to be Chief Financial Officer. Prior to joining Epizyme, from July 2007 to March 2010, Mr. Rhodes served as Vice President, Business Development at Alnylam Pharmaceuticals, Inc.

Prior to Alnylam, he was a founder and partner with Fidelity Biosciences, Fidelity Investments’ biopharma venture capital group. Mr. Rhod - July 4, 2013, Cambridge, Mass., USA – Epizyme, Inc., a clinical stage biopharmaceutical company, announced that Jason P. Rhodes has been named president of Epizyme.

Article continues below






Mr. Rhodes, who was previously Executive Vice President and Chief Financial Officer, will continue to be Chief Financial Officer. Prior to joining Epizyme, from July 2007 to March 2010, Mr. Rhodes served as Vice President, Business Development at Alnylam Pharmaceuticals, Inc.

LATEST 5 MOVES FROM  


What to read next

Epizyme appoints Susan Graf as chief business officer
Rackspace veteran Taylor Rhodes appointed president
CNA appoints Tony Rhodes Baltimore branch vice president